Combining Radiotherapy with Chemotherapy and Immunotherapy as First-Line Treatment for De Novo Metastatic Nasopharyngeal Carcinoma: A Dual-Center Retrospective Analysis

被引：0
|
作者：
Ma, L. [1 ,2 ]
Xiang, X. [1 ,2 ]
Lan, F. [1 ,2 ]
Chen, P. [1 ,2 ]
Lei, L. [1 ,2 ]
Zou, T. [1 ,2 ]
Wu, R. [3 ]
Zhang, J. [1 ,2 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Natl Clin Res Ctr Canc, Shenzhen, Guangdong, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Shenzhen Hosp, Shenzhen, Guangdong, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Natl Clin Res Ctr Canc,Dept Radiol Oncol, Beijing, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3321
引用
收藏
页码：E603 / E604
页数：2
相关论文
共 50 条
  • [1] Evaluating the reduction of elective radiotherapy fields for de novo metastatic nasopharyngeal carcinoma in the immunotherapy era
    Jin, Ting
    Li, Pei-Jing
    Jin, Qi-Feng
    Hua, Yong-Hong
    Chen, Xiao-Zhong
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2025, 47 (02): : 559 - 566
  • [2] A Scoring System Based on Nutritional and Inflammatory Parameters to Predict the Efficacy of First-Line Chemotherapy and Survival Outcomes for De Novo Metastatic Nasopharyngeal Carcinoma
    Li, Wang-Zhong
    Hua, Xin
    Lv, Shu-Hui
    Liang, Hu
    Liu, Guo-Ying
    Lu, Nian
    Bei, Wei-Xin
    Xia, Wei-Xiong
    Xiang, Yan-Qun
    JOURNAL OF INFLAMMATION RESEARCH, 2021, 14 : 817 - 828
  • [3] First-Line Immunochemotherapy Versus Palliative Chemotherapy Plus Definitive Radiation Therapy for de novo Metastatic Nasopharyngeal Carcinoma: A Matched Cohort Study
    Yang, Zhen-Chong
    Liu, Ting
    Chen, Yan-Zhou
    Guo, Chun-Yan
    Liu, Li-Ting
    Liu, Sai-Lan
    Chen, Qiu-Yan
    Mai, Hai-Qiang
    Guo, Shan-Shan
    CANCER CONTROL, 2022, 29
  • [4] Immunotherapy combined with chemotherapy without locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: two case reports and a literature review
    Gao, Yingna
    Shi, Xiaoqiong
    He, Jianqiao
    Yao, Hui
    Yu, Guoning
    Zhao, Lin
    Ma, Yi
    Zheng, Hongliang
    Zhu, Minhui
    Zhang, Caiyun
    FRONTIERS IN IMMUNOLOGY, 2025, 15
  • [5] Loco-regional radiotherapy in de novo metastatic nasopharyngeal carcinoma with chemotherapy and immunotherapy: A real-world retrospective study from two cancer centers
    Ma, Li
    Lan, Fengming
    Chen, Peng
    Lei, Ling
    Zou, Teng
    Fu, Fangmeng
    Wu, Runye
    Jin, Jing
    Zhang, Jianghu
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2024, 46 (08): : 1932 - 1937
  • [6] Comparative effectiveness analysis of first-line immunotherapy versus chemotherapy in metastatic urothelial carcinoma of the bladder
    Chakiryan, Nicholas H.
    Jiang, Da David
    Gillis, Kyle A.
    Green, Elizabeth
    Hajiran, Ali
    Hugar, Lee
    Zemp, Logan
    Zhang, Jingsong
    Jain, Rohit
    Chahoud, Jad
    Li, Roger
    Sexton, Wade
    Manley, Brandon J.
    Gilbert, Scott M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (03) : 107.e11 - 107.e17
  • [7] Immunotherapy in the First-Line Treatment of Advanced Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis
    Guven, Deniz Can
    Stephen, Bettzy
    Sahin, Taha Koray
    Cakir, Ibrahim Yahya
    Aksoy, Sercan
    LARYNGOSCOPE, 2024, 134 (01): : 7 - 17
  • [8] The efficacy of first-line chemotherapy in recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis
    Ma, Shu-Xiang
    Zhou, Ting
    Huang, Yan
    Yang, Yun-Peng
    Zhan, Jian-Hua
    Zhang, Ya-Xiong
    Zhang, Zhong-Han
    Zhao, Yuan-Yuan
    Fang, Wen-Feng
    Ma, Yu-Xiang
    Chen, Li-Kun
    Zhao, Hong-Yun
    Zhang, Li
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (11)
  • [9] Cost-effectiveness analysis of tislelizumab in combination with chemotherapy for the first-line treatment of patients with metastatic or recurrent nasopharyngeal carcinoma in China
    Tang, Yu-kai
    Xu, Zhe
    Ye, Zhuo-miao
    Li, Shi-ran
    Zhou, Qin
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2024, 46 (01): : 5 - 14
  • [10] Cost-effectiveness of camrelizumab combined with chemotherapy in the first-line treatment of recurrent or metastatic nasopharyngeal carcinoma in China
    Zhao, Ziying
    Chen, Tongfeng
    Zhou, Zhen
    Guo, Rui
    Liu, Qiao
    BMJ OPEN, 2023, 13 (12):
12345